Skip to main content
. 2015 Jun 1;10(6):e0128134. doi: 10.1371/journal.pone.0128134

Fig 5. A- The number of inflammatory cells (/mm2) in the study groups.

Fig 5

B- The number of osteoclasts (/mm2) in the study groups. C- The number of osteoblasts (/mm2) in the study groups. D- TAS in the study groups. E- TOS in the study groups. F- OSI levels in the study groups. * Significant difference compared to NL group. † Significant difference compared to LO.